SI 2026/680 - The Food Supplements Purity Criteria (Magnesium L-threonate monohydrate) (England) Regulations 2026

Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format. STATUTORY INSTRUMENTS 2026 No. 680 FOOD, ENGLAND The Food Supplements Purity Criteria (Magnesium L- threonate monohydrate) (England) Regulations 2026 Made - - - - 22nd June 2026 Coming into force - - 13th August 2026 The Secretary of State makes these Regulations in exercise of the powers conferred by regulation 3 and in accordance with regulation 5(1) of the Nutrition (Amendment etc.) (EU Exit) Regulations 2019 (“the 2019 Regulations”)(1). There has been open and transparent consultation in accordance with Article 9 of Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety(2). In accordance with regulation 6(3) of the 2019 Regulations, a draft of this instrument has been laid before Parliament and approved by a resolution of each House of Parliament. Citation, commencement, extent and application 1.—(1) These Regulations may be cited as the Food Supplements Purity Criteria (Magnesium L-threonate monohydrate) (England) Regulations 2026 and come into force on 13th August 2026. (2) These Regulations extend to England and Wales. (3) These Regulations apply to England only. Purity criteria for magnesium L-threonate monohydrate 2. The purity criteria for magnesium L-threonate monohydrate are set out in the Schedule to these Regulations. (1) S.I. 2019/651, amended by S.I. 2026/412. There are other amending instruments but none are relevant. These powers are exercised by the Secretary of State who is the “appropriate authority” for regulations applying in relation to England, as defined in regulation 5(4)(a). (2) EUR 2002/178, to which there are other amending instruments but none are relevant.Document Generated: 2026-06-29 Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format. Signed by authority of the Secretary of State for Health and Social Care L.S. Sharon Hodgson Parliamentary Under-Secretary of State 22nd June 2026 Department of Health and Social Care 2Document Generated: 2026-06-29 Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format. Schedule Regulation 2 PURITY CRITERIA FOR MAGNESIUM L-THREONATE MONOHYDRATE Synonym Magnesium L-threonate Definition Chemical name Magnesium (2R,3S)-2,3,4-trihydroxybutanoate monohydrate CAS number 500304-76-7(3) Chemical formula C H MgO 8 16 11 Molecular weight 312.51 Da Colour (solid) White Assay Magnesium: 7.2% to 8.3% L-threonate: 82% to 91% Description A water-soluble white powder which is manufactured via a chemical synthetic process. Identification Solubility Soluble in water at 1% concentration at 25# and that is clear in solution at 1% concentration. pH USP(4) (1% in H#O) 5.8 to 7.0 Purity Loss on drying Not more than 5.0% (105#/4 hours) Oxalic acid/oxalate Not more than 0.5% (as oxalic acid) Arsenic Not more than 1 ppm Lead Not more than 0.5 ppm Cadmium Not more than 0.2 ppm Mercury Not more than 0.1 ppm (3) This is a reference to the CAS Registry Number assigned to this preparation by the Chemical Abstracts Service. This is available at https://www.cas.org/cas-data/cas-registry (4) United States Pharmacopoeia (USP), published by the United States Pharmacopeial Convention in Rockville, Maryland, USA. General Chapter 791 pH of the USP was revised in 2014 by a Supplement to the USP, published on 1st December 2014 (ISBN number 1936424223). USP is a nonprofit scientific organisation that develops and disseminates public compendial quality standards for medicines and other articles. The USP is available at https://www.usp.org 3Document Generated: 2026-06-29 Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format. EXPLANATORY NOTE (This note is not part of the Regulations) These Regulations set the purity criteria for the mineral substance magnesium L-threonate monohydrate, as a source of magnesium, as set out in the Schedule to these Regulations (regulation 2). An impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or public sector is foreseen. An Explanatory Memorandum has been published alongside this instrument at www.legislation.gov.uk. 4